Increasing evidence has shown that proper control of mitochondrial dynamics (fusion and fission) is required for high-capacity ATP production in the heart. Transcriptional coactivators, peroxisome proliferatoractivated receptor γ coactivator-1 (PGC-1) α and PGC-1β, have been shown to regulate mitochondrial biogenesis in the heart at the time of birth. The function of PGC-1 coactivators in the heart after birth has been incompletely understood.
H
igh energy demands of the postnatal heart are largely satisfied by ATP generated via mitochondrial oxidative phosphorylation (OXPHOS). Accordingly, cardiac myocytes require a specialized, high-capacity mitochondrial system. The importance of mitochondrial respiration for proper heart function is demonstrated by the tight linear relationship between cardiac oxygen consumption and work. 1 Evidence is emerging that in many forms of heart failure, cardiac mitochondria revert to prenatal levels of function and morphology, leading to energy starvation, contributing to a vicious pathological cycle. 2, 3 During cardiac development, mitochondria undergo a maturation process. Mitochondrial maturation can be divided into 3 main developmental stages: prenatal, perinatal, and postnatal. In the prenatal stage, the early embryonic heart relies largely on nonmitochondrial energy sources (ie, anaerobic glycolysis). 4 During the transition from late fetal to postnatal periods (perinatal stage), the mitochondrial functional capacity of the heart increases dramatically, supporting a switch to reliance on fatty acids as the chief energy substrate. [4] [5] [6] This increase in mitochondrial oxidative capacity is triggered by a burst of mitochondrial biogenesis at birth. [7] [8] [9] The third stage of mitochondrial maturation occurs during the postnatal period when the cardiac myocyte undergoes growth, elongation, and assembly of adult sarcomeres. This final stage involves an increase in mitochondrial size and function, together with redistribution of the organelles throughout the myocyte. 6 This intracellular redistribution results in the mitochondria being tightly packed between the longitudinally oriented myofibrils with the development of contacts between mitochondria, myofibrils, and the sarcoplasmic reticulum. 6 The mitochondrial architectural arrangement of the adult myocyte facilitates efficient high-energy phosphate transfer between the mitochondria and key ATPases such as the myosin ATPase and the sarcoplasmic reticulum ATPase. 10 Recent evidence suggests that postnatal mitochondrial maturation in the mammalian heart involves coordinated mitochondrial dynamics (fusion and fission). 11 The mechanisms regulating mitochondrial maturation are incompletely understood. Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and PGC-1β are inducible, developmentally regulated transcriptional coregulators of cellular energy processes, including OXPHOS and fatty acid oxidation, in mitochondrial-rich tissues such as the heart, skeletal muscle, and brown adipose tissue. [12] [13] [14] [15] Using conditional gene-targeting strategies in mice, we have shown that PGC-1α and PGC-1β serve overlapping roles in the surge of mitochondrial biogenesis that occurs in the heart immediately after birth. 12 The combined disruption of PGC-1α and PGC-1β genes during the embryonic period resulted in a complete arrest of cardiac perinatal mitochondrial biogenesis, leading to a lethal cardiomyopathy soon after birth. 12 Conversely, the overexpression of PGC-1α in the immediate postnatal period drives an exuberant mitochondrial biogenic response. 16 The PGC-1 loss-of-function studies to date have not defined the role of these transcriptional coactivators during postnatal development or in the adult heart due to the lethal phenotype of PGC-1α/PGC-1β-deficient mice shortly after birth. The role of PGC-1 coactivators after birth is an important question given the potential link of altered PGC-1 signaling to the development of heart failure. 17, 18 To address this question, we took advantage of a conditional gene-targeting system in mice that resulted in the deletion of PGC-1β gene in both heart and skeletal muscle via the actions of Cre recombinase driven by the muscle creatine kinase (MCK) promoter (MCK-Cre) on a generalized PGC-1α-null background (PGC-1α −/− β f/f/MCK-Cre ). 19, 20 MCK-Cre is not fully active in the heart until after the perinatal mitochondrial biogenic surge. We found that loss of both PGC-1α and PGC-1β (but not either alone) during postnatal cardiac development resulted in dramatic defects in mitochondrial maturation and structure associated with reduced expression of genes involved in mitochondrial fusion and fission, leading to a progressive lethal cardiomyopathy. In striking contrast, the disruption of PGC-1 genes in the adult heart did not result in evidence of altered mitochondrial dynamics. These results reveal the importance of PGC-1 coactivators for postnatal mitochondrial dynamics, maturation, and cardiac function. Our findings also suggest that the upstream pathways involved in the control of cardiac mitochondrial dynamics are developmental stage-specific.
Methods
A detailed Methods section is available in the Online Data Supplement. Animal studies were conducted in strict accordance with the National Institutes of Health guidelines for humane treatment of animals and approved by the Institutional Animal Care and Use Committee at the Sanford-Burnham Medical Research Institute at Lake Nona. The gene array data discussed in this article have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus (GEO) and are accessible through GEO accession number GSE43798.
Results

PGC-1 Coactivators Are Required for Normal Postnatal Cardiac Development
Mice deficient for both PGC-1α and PGC-1β in heart and skeletal muscle (PGC-1α −/− β f/f/MCK-Cre mice) were generated by crossing mice with skeletal muscle-and heart-specific disruption of the PGC-1β gene via Cre recombinase driven by an MCK promoter (PGC-1β f/f/MCK-Cre mice) to whole-body PGC-1α-deficient mice. 19, 20 MCK promoter expression is activated during the late fetal stages and, to a greater extent, the early postnatal period. 21 Accordingly, cardiac levels of PGC-1β mRNA in PGC-1α −/− β f/f/MCK-Cre were 30% of control at time of birth with progressive reduction during the postnatal period (Online Figure I) . In contrast to the early postnatal lethality of mice with complete prenatal targeting of the PGC-1 genes, 12 the PGC-1α −/− β f/f/MCK-Cre mice survive the perinatal period. However, the PGC-1α −/− β f/f/MCK-Cre mice exhibit a lethal phenotype beginning at 5 weeks of age with only 14% survival by 20 weeks ( Figure 1A) .
To investigate the cause of death in the PGC-1α −/− β f/f/ MCK-Cre line, echocardiography was performed across several postnatal time points. Compared with wild-type (αβ +/+ ) and single PGC-1α-or PGC-1β-deficient mice, the PGC-1α −/− β f/f/MCK-Cre mice exhibited a progressive cardiomyopathy beginning at 1 week of age ( Figure 1B and 1C) . At 8 weeks of age, the mean percent left ventricular fractional shortening and ejection fraction of the PGC-1α −/− β f/f/MCK-Cre hearts were decreased by 68% and 67%, respectively, compared with αβ +/+ control animals ( Figure 1B ; Online Table II) . Notably, significant cardiac remodeling, as reflected by the expansion of chamber dimensions and relative wall thickness, did not occur until 8 weeks of age in the PGC-1α −/− β f/f/ MCK-Cre mice (Online Table II ). Only minimal fibrosis was noted in the PGC-1α −/− β f/f/MCK-Cre hearts at 4 weeks of age with a significant increase thereafter ( Figure 1D ; Online Figure  II ). There was no evidence of fibrosis in single PGC-1α-or PGC-1β-knockout animals at any time point (data not shown). In addition, caspase immunostaining was negative at all time points, in all genotypes, suggesting that apoptosis is an unlikely major primary cause of cardiomyopathy (Online Figure III) . As an initial step to determine the basis for the cardiomyopathy of PGC-1α −/− β f/f/MCK-Cre mice, electron microscopy assessment of the myocardium was conducted across postnatal time points. Consistent with the survival of PGC-1α −/− β f/f/MCK-Cre mice at birth, the PGC-1α −/− β f/f/MCK-Cre hearts had normal mitochondrial density and structure on postnatal day 1, indicating that the mitochondrial biogenic surge at birth remained largely intact (Figure 2A ). However, striking mitochondrial morphological abnormalities were noted in the PGC-1α −/− β f/f/MCK-Cre hearts by 1 week of age, including fragmented and elongated mitochondria and a reduction in direct contacts between mitochondria and the sarcomeres ( Figure 2B ). The mitochondria of 4-week-old PGC-1α −/− β f/f/ MCK-Cre mice displayed increased heterogeneity in size and shape ( Figure 2B ). By 8 weeks of age, further mitochondrial derangements were present, including collapsed cristae and ring-like or donut-shaped mitochondria, in addition to a decrease in mitochondrial density and more pronounced loss of contacts between mitochondria and the sarcomeres ( Figure 2B ). Mitophagosomes were not observed. The observed decrease in mitochondrial density by electron microscopy at 8 weeks was associated with a 35% decrease in mitochondrial DNA ( Figure 2C ) and a decrease in the levels of complex I (8 kD subunit) and IV (COX IV) proteins. In contrast, complex II (SDHA) protein levels were unchanged (Online Figure IV) . Abnormalities in mitochondrial density and structure were not detected in the hearts of single PGC-1-knockout animals (data not shown), consistent with what we have reported previously. 20 Respiration rates were determined on mitochondria isolated from PGC-1α −/− β f/f/MCK-Cre mice compared with age-matched controls. Mitochondria from cardiac ventricles of 4-week-old PGC-1α −/− β f/f/MCK-Cre hearts exhibited a severe reduction in state 3 respiration rates using either pyruvate or palmitoylcarnitine as substrates ( Figure 2D ). Single PGC-1α-knockout animals displayed a modest reduction in respiration rates relative to control mice (data not shown), consistent with the original description of this line.
Derangements in Mitochondrial
20
Evidence for Regulation of Cardiac Mitochondrial Fusion and Fission Genes by PGC-1 Coactivators During Postnatal Development
The mitochondrial structural abnormalities identified in the hearts of PGC-1α −/− β f/f/MCK-Cre mice suggested derangements in mitochondrial fusion and fission (dynamics). Indeed, fragmented, elongated, and donut-shaped forms have been described in mouse models and humans with genetic defects in the mitochondrial fusion machinery, such as Charcot-Marie-Tooth disease, an inherited motor neuronopathy. [22] [23] [24] [25] [26] The expression of a panel of genes encoding proteins known to be involved in mitochondrial fusion (Mfn1, Mfn2, Opa1) and fission (Fis1, and Dnm1l or Drp1) was assessed in the hearts from PGC-1α −/− β f/f/MCK-Cre mice at birth, and 1, 4, and 8 weeks of age. The expression of this group of genes was induced during the postnatal period in αβ +/+ control animals ( Figure 3A , white bars). This pattern of induction was markedly altered, in a gene-specific manner, in PGC-1α −/− β f/f/MCK-Cre hearts ( Figure 3A , black bars). Notably, Mfn1 mRNA and protein levels were significantly decreased across all time points in PGC-1α −/− β f/f/MCK-Cre hearts compared with controls ( Figure 3A and 3B). This was also true for Opa1 ( Figure 3A and 3B). A progressive decrease in Fis1 protein levels was also noted during the late postnatal period. In contrast, Mfn2 mRNA levels were only modestly reduced, and Mfn2 protein levels were not different than control levels at any time point.
To determine whether reduced expression of Opa1 and Mfn1 is sufficient to cause mitochondrial morphological . Low-magnification images were used to evaluate mitochondrial density, and high-magnification images were used to determine mitochondrial structure. Images from 4 animals of each genotype were examined. Scale bars are 1μm. B, Representative EMs of LV free wall of 1-week-old mice and papillary muscle of 4-and 8-week-old mice from the genotypes indicated are shown. Arrows indicate structurally abnormal mitochondria including mitochondria with abnormal cristae structure (black arrows), elongated (black arrowheads), donut-shaped (white arrows), and small fragmented mitochondria (white arrowheads). C, PCR of DNA from heart of PGC-1β
) mice was performed to quantify mitochondrial DNA using primers for NADH dehydrogenase (ND1) normalized to genomic DNA using primers for lipoprotein lipase (LPL). The ND1 levels were normalized to genomic DNA content. Bars represent mean±SEM. *P<0.05. D, Bars represent mean (±SEM) mitochondrial respiration rates determined on mitochondria isolated from the entire heart ventricle of 4-week-old female mice from the indicated genotypes. Rates were measured using a fluorescence-based oxygen-sensing probe (FOXY; Ocean Optics) with either pyruvate or palmitoylcarnitine as substrate under the following conditions: basal, state 3 (ADP stimulated), and oligomycin-induced state 4 (oligo). *P<0.05 relative to αβ
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changes seen in PGC-1α −/− β f/f/MCK-Cre hearts, microRNAs were used to knockdown (KD) Opa1 and Mfn1 in C2C12 myocytes. In differentiated C2C12 myotubes, KD of Mfn1 or Opa1 alone had no effect on mitochondrial morphology; however, combined KD of Opa1 and Mfn1 caused mitochondrial fragmentation (Online Figure V) . Interestingly, KD of either Mfn1 or Opa1 alone caused fragmentation in C2C12 myoblasts (data not shown). These results suggest that decreased expression of Opa1 and Mfn1, as it occurs in PGC-1α −/− β f/f/MCK-Cre heart, is sufficient to cause a mitochondrial fragmentation phenotype.
The abnormal expression of Mfn1 gene in PGC-1α −/− β f/f/ MCK-Cre hearts was of particular interest given recent evidence demonstrating the importance of Mfn1 and Mfn2 for mitochondrial fusion and maturation during embryonic 27 and postnatal cardiac development. 11 To explore the link between PGC-1 signaling and the expression of Mfn1 and Mfn2, the effect of adenoviral-mediated overexpression of PGC-1α was assessed in neonatal rat cardiac myocytes in culture. The overexpression of PGC-1α or PGC-1β increased the expression of Mfn1 and Mfn2 ( Figure 4A ). Conversely, shRNA-mediated KD of PGC-1α and PGC-1β resulted in a modest but significant decrease in Mfn1 and Mfn2 mRNA levels ( Figure 4B ). KD of either PGC-1α or PGC-1β, independently, did not decrease Mfn1 or Mfn2 mRNA levels (data not shown). Taken together, these results suggest that PGC-1α and PGC-1β regulate the expression of Mfn1 and Mfn2, but that in PGC-1α −/− β f/f/MCK-Cre heart, independent regulatory pathways maintain Mfn2 levels.
PGC-1 Activates Mfn1 Gene Transcription Via Estrogen-Related Receptor α
We next sought to determine whether PGC-1α directly activates Mfn1 gene transcription. To this end, Mfn1 promoter-reporter studies were conducted in C2C12 myotubes. Cotransfection studies were performed using a PGC-1α expression vector and a luciferase reporter containing ≈3.5kb fragment of the mouse Mfn1 promoter region (mMfn1.Luc.−2996/+492). PGC-1α significantly activated mMfn1.Luc.−2996/+492 ( Figure 5A, left) . The analysis of the DNA sequence of Mfn1 promoter region revealed 2 consensus-binding sites for estrogen-related receptor (ERR), a known target of PGC-1α, [28] [29] [30] located 2826 bp upstream and 110 bp downstream of the transcription start site (Figure 5A, right) . The latter, which is present in an untranslated exon 1, is highly conserved across species ( Figure 5A, right) . Deletion of the region containing the upstream putative ERRα-binding site (mMfn1. Luc.−2299/+492) had no effect on PGC-1-mediated induction of the promoter ( Figure 5A, left) . However, removal of a region containing the conserved ERRα-binding site (mMfn1.Luc.−2299/+70) abolished PGC-1-mediated activation ( Figure 5A, left) . Similar results were obtained with PGC-1β (Online Figure VI) .
To further evaluate the functionality of conserved putative ERRα-binding site, Mfn1 promoter-reporter experiments were performed in undifferentiated 10T1/2 cells, which express very low levels of endogenous ERRα and PGC-1α (data not shown). Forced expression of PGC-1 alone conferred a modest activating effect on mMfn1. Luc.−2299/+492 ( Figure 5B ), whereas ERRα alone had no effect, consistent with its dependence on PGC-1α for its transcriptional activating function ( Figure 5B ). Cotransfection of both PGC-1α and ERRα activated mMfn1. Luc.−2299/+492 in a synergistic manner ( Figure 5B ). The cooperative effect of PGC-1α and ERRα was not observed with a reporter that lacks the conserved +110/+119 ERRα-binding site (mMfn1.Luc.−2299/+70; Figure 5B ). Next, a reporter containing 2 copies of a Mfn1 promoter fragment containing the conserved +110/+119 putative ERRα-binding site upstream of the HSV thymidine kinase promoter (Mfn1ERR-RE 2 .TK.Luc) was assessed. Whereas neither PGC-1α nor ERRα alone had a significant effect on Mfn1ERR-RE 2 .TK.Luc activity, together they activated the reporter >10-fold ( Figure 5C ). In contrast, a reporter construct containing a mutated version of the ERR element (Mfn1ERR-RE 2mut .TK.Luc) did not confer activation by PGC-1α/ERRα ( Figure 5C ).
Chromatin immunoprecipitation studies were performed to assess the occupation of PGC-1α and ERRα on Mfn1 promoter region using chromatin isolated from H9c2 myotubes after infection with an adenoviral expression vector for PGC-1α and GFP (adPGC-1α) or control virus (adGFP). Antibodies specific to ERRα and PGC-1α significantly enriched the endogenous Mfn1 promoter region ( Figure 5D ) in conditions in which PGC-1 was not overexpressed (adGFP). The enrichment was further increased in the adPGC-1α condition ( Figure 5D ). In contrast, neither ERRα nor PGC-1α antibodies enriched a distal (control) region of the Slc24a (GLUT4) gene ( Figure 5D ), demonstrating the specificity of the immunoprecipitation results. Taken together, these results confirm that PGC-1α and ERRα occupy the ERRα-responsive region of the Mfn1 promoter to increase its transcription.
Hearts of Adult PGC-1α/β-Deficient Mice Do Not Exhibit Evidence of Altered Mitochondrial Dynamics
To determine if PGC-1 coactivators are also important for maintenance of mitochondrial density and structure in the adult heart, an inducible PGC-1 gene-targeting strategy was undertaken. To this end, transgenic mice with the tamoxifen-inducible Cre recombinase driven by the cardiac-specific myosin heavy chain promoter 31 were crossed to PGC-1β f/f mice and, subsequently, with whole-body PGC-1α-deficient mice 20 Figure 6A ). However, increased numbers of lipid droplets were noted compared with the controls ( Figure 6A ). In addition, some cristae appeared dense and collapsed in a subset of mitochondria ( Figure 6A ). The significance of this is unknown. The levels of several known PGC-1α isoforms were assessed using qRT-PCR in hearts of adult, tamoxifen-treated, PGC-1α −/− β f/f/MerCre mice to ensure that upregulation of these transcripts did not occur in the context of markedly reduced PGC-1β expression in the adult heart. The levels of transcripts encoding full-length PGC-1α and 2 shorter alternatively spliced forms of PGC-1α (NT-PGC-1α 32 and PGC-1α4 33 ) were markedly reduced in the hearts of adult PGC-1α/β-deficient mice relative to age-matched controls (Online Figure VIIC) .
To further explore the impact of PGC-1α/β deficiency in adult heart, transcriptional profiling was conducted on 12-week-old, tamoxifen-treated, PGC-1α Table III ). Of particular interest was downregulation of genes involved in mitochondrial energy transduction and ATP-generating pathways, including the citric acid cycle, fatty acid metabolism, and OXPHOS pathways (Online Table IV ; Figure 6B ). Consistent with transcriptional profiling results, state 3 respiration rates were reduced in mitochondria isolated from tamoxifen-injected PGC-1α −/− β f/f/MerCre hearts ( Figure 6C ). Importantly, qRT-PCR ( Figure 6D ) and protein immunoblotting (Online Figure VIID) confirmed that the expression of Mfn1 and other fusion/fission genes was dysregulated in adult, tamoxifentreated PGC-1α 
Discussion
Emerging evidence indicates that mitochondrial dynamics (fusion and fission) serves a critical function in cellular distribution, maturation, and quality control of mitochondria. 11, 34 The results herein unveil a role for transcriptional coactivators PGC-1α and PGC-1β as key upstream regulators of the mitochondrial dynamics machinery during postnatal growth of the heart. Our results support the following conclusions: (1) PGC-l coactivators are necessary for normal mitochondrial maturation, dynamics, and cardiac function during postnatal development; (2) PGC-1 coactivators regulate the expression of a subset of cardiac genes involved in mitochondrial fusion and fission; (3) PGC-lα directly stimulates the transcription of Mfn1 gene by coactivating the orphan nuclear receptor ERRα; and (4) PGC-1 coactivators are not necessary for maintenance of mitochondria in the adult heart, but are required for a high-level expression of nuclearand mitochondrial-encoded genes involved in mitochondrial energy transduction and OXPHOS pathways, and for full respiratory capacity.
The postnatal hearts of PGC-1α −/− β f/f/MCK-Cre mice exhibited dramatic evidence of derangements in mitochondrial dynamics, including fragmented, elongated, and donut-shaped mitochondria. Consistent with these findings, the expression of genes encoding proteins involved in mitochondrial fusion (Mfn1 and Opa1) and fission (Drp1 and Fis1) was reduced in the hearts of PGC-1α −/− β f/f/MCK-Cre mice. Among these genes, we identified Mfn1 as a direct PGC-1 target. PGC-1α was shown to coactivate the nuclear receptor 
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ERRα on a conserved element in Mfn1 gene. However, ERRα sites were not identified in the upstream regions of other downregulated fusion/fission genes, although a functional nonclassical PGC-1-responsive ERR site has been described previously in the Mfn2 gene promoter. 35, 36 Indeed, our cell culture overexpression studies ( Figure 4A ) demonstrated that PGC-1α and PGC-1β are capable of inducing both Mfn1 and Mfn2 expression. Surprisingly, however, the levels of Mfn2 mRNA and protein were not significantly downregulated in PGC-1α −/− β f/f/MCK-Cre hearts. These results indicate that full activity of both mitofusins is necessary to support mitochondrial dynamics during the postnatal growth phase of heart development. Our findings also suggest that upstream regulatory pathways in addition to PGC-1 signaling serve to maintain Mfn2 expression during the postnatal growth phase. To this point, the transcription factor Sp1 has also been implicated in the transcriptional control of Mfn2. 37 It should also be noted that a subset of mitochondrial respiratory complexes (I and IV) and mtDNA levels were decreased in PGC-1α −/− β f/f/MCK-Cre hearts. Taken together, these results suggest that mitochondrial and cardiac phenotypes are driven by a combination of altered dynamics and biogenesis.
In striking contrast to the postnatal cardiac phenotype, loss of PGC-1 coactivator function did not result in evidence of mitochondrial fragmentation and other features of altered fusion/fission in the adult mouse heart. This observation was surprising, given that Mfn1 mRNA and protein levels were reduced to a similar extent in both models. These results suggest that the activity of mitochondrial dynamics and its control is developmental stage-specific in the heart. Consistent with this notion, rates of mitochondrial fusion and fission have been shown to be very low in adult cardiac myocytes 38, 39 compared with those of neonatal cardiac myocytes. 40, 41 Thus, loss of function of a single mitofusin gene could have a greater impact during periods of intense mitochondrial fusion and fission as it occurs during postnatal myocyte growth and maturation. Accordingly, the full activity of both Mfn1 and Mfn2, driven in part by the boosting activity of PGC-1 coactivators, is likely required during the cardiac postnatal stage, but not in the adult. Consistent with this possibility, the mitochondrial phenotypes of single Mfn1 and Mfn2 mouse knockouts in adult the heart and skeletal muscle are mild compared with the severe consequences of combined loss of function. 11, 38, [42] [43] [44] [45] A second possibility is that the mitofusins serve a subset of distinct biological roles. For example, high rates of mitochondrial fusion, as it occurs during the postnatal period, may be directed largely by Mfn1 downstream of the boosting function of PGC-1 coactivators. In contrast, other functions linked to the fusion/fission cycle, such as quality control via sorting for mitophagy, 34, 46 may be performed in the adult heart by Mfn2.
Evidence is emerging that mitochondrial dynamics serves important roles in the maintenance of cardiac function and adaptation to stressful perturbations such as ischemia/reperfusion. [47] [48] [49] Targeted disruption of the Drosophila ortholog of mammalian mitofusins (mitochondrial assembly regulatory factor) 45 and of Mfn1 and Mfn2 in mice 11, 38 caused cardiomyopathy associated with altered mitochondrial structure. Given the potential pathogenic role of reduced PGC-1/ERR signaling and mitochondrial dysfunction in the development of heart failure, 46, 50, 51 these results suggest that altered mitochondrial dynamics could contribute to pathological remodeling, leading to some forms of heart failure. For example, the results shown herein also raise the possibility that derangements in mitochondrial dynamics should be considered in the pathogenesis of childhood cardiomyopathies.
The lack of an obvious cardiac functional phenotype in adult PGC-1α −/− β f/f/MerCre mice was surprising. PGC-1α −/− β f/f/MerCre hearts exhibited a global downregulation of genes involved in mitochondrial energy transduction and OXPHOS pathways along with reduced state 3 respiration rates. However, despite widespread alterations in genes involved in mitochondrial ATP production and reduced capacity for respiration, cardiac function was maintained in adult PGC-1α/β-deficient mice. These results suggest that the mitochondrial system of the adult mammalian heart has tremendous reserve for ATP production under basal, nonstressed conditions. It is possible that processes such as energy transfer rather than ATP production capacity per se serve as the limiting factor for energy homeostasis in the heart. Importantly, the adult PGC-1α −/− β f/f/MerCre heart did not exhibit morphological evidence of significant alterations in mitochondrial dynamics. It is tempting to speculate that mitochondrial structural organization, including appropriate juxtaposition with the myofilaments, which was maintained in the adult but not postnatal PGC-1α/β −/− hearts, is a critical determinant for maintaining adequate ATP production and transfer to the contractile apparatus.
